» Articles » PMID: 16380095

3,3'-Diindolylmethane Downregulates Pro-survival Pathway in Hormone Independent Prostate Cancer

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2005 Dec 29
PMID 16380095
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological evidences suggest that the progression and promotion of prostate cancer (CaP) can be modulated by diet. Since all men die with prostate cancer rather than of the disease, it is of particular interest to prevent or delay the progression of the disease by chemopreventive strategies. We have been studying the anticancer properties of compounds present in cruciferous vegetables such as indole-3-carbinol (I3C). Diindolylmethane (DIM) is a dimer of I3C that is formed under acidic conditions and unlike I3C is more stable with higher anti-cancer effects. In the present report, we demonstrate that DIM is a potent anti-proliferative agent compared to I3C in the hormone independent DU 145 CaP cells. The anti-prostate cancer effect is mediated by the inhibition of the Akt signal transduction pathway as DIM, in sharp contrast to I3C, induces the downregulation of Akt, p-Akt, and PI3 kinase. DIM also induced a G1 arrest in DU 145 cells by flow cytometry and downstream concurrent inhibition of cell cycle parameters such as cyclin D1, cdk4, and cdk6. Our data suggest a need for further development of DIM, as a chemopreventive agent for CaP, which justifies epidemiological evidences and molecular targets that are determinants for CaP dissemination/progression. The ingestion of DIM may benefit CaP patients and reduce disease recurrence by eliminating micro-metastases that may be present in patients who undergo radical prostatectomy.

Citing Articles

Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels.

Wang D, Neupane P, Ragnarsson L, Capon R, Lewis R Membranes (Basel). 2022; 12(8).

PMID: 36005664 PMC: 9412534. DOI: 10.3390/membranes12080749.


Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies.

Singla R, Sharma P, Dubey A, Gundamaraju R, Kumar D, Kumar S Front Pharmacol. 2021; 12:732266.

PMID: 34737700 PMC: 8560712. DOI: 10.3389/fphar.2021.732266.


Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3'-diindolylmethane in an enzalutamide-resistant prostate cancer cell line.

Tsao C, Li J, Lin Y, Wu S, Cha T, Liu C Sci Rep. 2021; 11(1):1239.

PMID: 33441906 PMC: 7806813. DOI: 10.1038/s41598-020-80519-3.


Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.

Prabhu B, Sivakumar A, Sundaresan S Pathol Oncol Res. 2016; 22(4):747-54.

PMID: 27091758 DOI: 10.1007/s12253-016-0054-9.


Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.

Hwang C, Sethi S, Heilbrun L, Gupta N, Chitale D, Sakr W Am J Transl Res. 2016; 8(1):166-76.

PMID: 27069550 PMC: 4759426.